| Title | Download |
|---|---|
| Demise of Dr. Christopher M Cimarusti, Non-Executive Non-Independent Director of the Company | |
| Intimation regarding conversion of Statutory Auditor's Firm to a LLP | |
| Disclosure under Regulation 30 of SEBI Listing Regulations - Clarification on movement in volume | |
| Disclosure under Regulation 30 of SEBI Listing Regulations - Intimation regarding completion of US FDA inspection Unit 2 | |
| Intimation under Regulation 30 of SEBI Listing Regulation | |
| Disclosure Under Regulation 30 Of SEBI Listing Regulations | |
| Compliance Certificate Pursuant to SEBI Exemption Order Dated January 3, 2025 for the Financial Year Ended March 31, 2025 | |
| Neuland Press Release Q3 FY26 | |
| Intimation under Regulation 30 of SEBI Listing Regulations | |
| Neuland Press Release Q2 FY26 | |
| Change in Designation | |
| Intimation Under Regulation 30 Of SEBI Listing Regulations | |
| Neuland Press Release Q1 FY26 | |
| Secretarial Compliance Report – FY 25 | |
| Completion of tenure of Independent Director | |
| Intimation regarding completion of US FDA inspection - Unit 2 |
| Title | Download |
|---|---|
| Neuland Press Release Q4 FY25 | |
| Appointment of Senior Management Personnel_10032025 | |
| Neuland Press Release Q3 FY25 | |
| Intimation under Regulation 30 of SEBI Listing Regulations | |
| Update on final transfer of part of Nanakramguda property | |
| Update on further transfer of part of Nanakramguda property | |
| Neuland Press Release Q2 FY25 | |
| Clarification on recent news in the media / social media | |
| Announcement under Regulation 30 of SEBI LODR | |
| Announcement under Regulation 30 of SEBI LODR | |
| Announcement under Regulation 30 of SEBI LODR - Capacity Addition - August 1, 2024 | |
| Neuland Press Release Q1 FY25 | |
| Press Release – Change in the logo of the Company | |
| Secretarial Compliance Report – FY 24 | |
| Board Meeting Outcome for Recommendation Of Final Dividend For The Financial Year 2023-24 | |
| Book Closure For Dividend And Annual General Meeting Scheduled On Wednesday, July 31, 2024 | |
| Certificate Under Regulation 40(10) Of SEBI(LODR) Regulations, 2015 | |
| Change in Directorate_Mrs. Bharati Rao_Term Completion | |
| Compliance Certificate- Regulation 7(3) Of SEBI(LODR) Regulations, 2015, For The Year Ended March 31, 2024 | |
| Compliances - Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | |
| Re-Appointment Of Statutory Auditors | |
| Regulation 30 - GST Order | |
| Update on pending Litigation |
| Title | Download |
|---|---|
| Amendments to Memorandum & Articles of Association | |
| Appointment of Directors | |
| Book Closure For Dividend And Annual General Meeting Scheduled On Thursday, July 27, 2023 | |
| Certificate Under Regulation 40(10) Of SEBI(LODR) Regulations, 2015 | |
| Change in Directorate_Mr. Maiya_Term Completion | |
| Change in Management_CQO Appointment | |
| Change in Management_CSO Appointment | |
| Change in Management_Resignation | |
| Compliance Certificate- Regulation 7(3) Of SEBI(LODR) Regulations, 2015, For The Year Ended March 31, 2023 | |
| Compliances-Reg.24(A)-Annual Secretarial Compliance | |
| Disclosure Of Related Party Transactions For The Half Year Ended March 31, 2023 | |
| Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | |
| Initial Disclosure to be made by an entity identified as a Large Corporate_FY24 | |
| Intimation Of S&P Global ESG Score, 2023 | |
| Intimation Regarding Completion Of US FDA Inspection_Unit 3 | |
| Issue of LOC_07112023 | |
| Issue of LOC_12042023 | |
| Issue of LOC_18102023 | |
| Issue of LOC_20092023 | |
| Issue of LOC_22052023 | |
| Issue of LOC_26022024 | |
| Issue of LOC_30082023 | |
| Loss of SC_02102023 | |
| Loss of SC_03042023 | |
| Loss of SC_08052023 | |
| Loss of SC_12022024 | |
| Loss of SC_20102023 | |
| Pending Litigation and Dispute | |
| Reg 30 - Capex Approval | |
| Reg 30 - Purchase of land | |
| Resignation of Director | |
| US FDA inspection_Unit 1 |
| Title | Download |
|---|---|
| Appointment of Director | |
| Board recommends Final Dividend | |
| CFO Appointment | |
| Change Of Name Of Risk Management Committee Of The Company | |
| Clarification Letter Dated 15072022 | |
| Clarification Letter Dated 23092022 | |
| Clarification On Price Movement | |
| Compliance Certificate- Regulation 7(3) Of SEBI(LODR) Regulations, 2015, For The Year Ended March 31, 2022 | |
| Compliances- Certificate Under Regulation 40(10) Of SEBI(LODR) Regulations, 2015 | |
| Compliances-Reg.24(A)-Annual Secretarial Compliance | |
| Disclosure Of Related Party Transactions For H1 FY23 | |
| Disclosure On Related Party Transactions For The Half Year Ended March 31, 2022 | |
| Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | |
| Initial Disclosure to be made by an entity identified as a Large Corporate_FY23 | |
| Intimation Of S&P Global ESG Score, 2022 | |
| Intimation Of Withdrawal Of Application For Reclassification Of Promoter and Promoter Group Category To Public Category | |
| Issue of LOC_13122022 | |
| Issue of LOC_14022023 | |
| Loss of SC_01022023 | |
| Loss of SC_08062022 | |
| Reg 30_Policy on determination of materiality of events or information | |
| Resignation of Chief Financial Officer (CFO) | |
| Transfer Of Company'S Property Situated At Nanakramguda, Hyderabad By Way Of Perpetual Lease |
| Title | Download |
|---|---|
| Approval Of The Board Of Directors For Re-Classification Of Persons From Promoters Group To Public Category Shareholders | |
| Change In Name Of Share Transfer Agent | |
| Compliance Certificate- Regulation 7(3) Of SEBI(LODR) Regulations, 2015, For The Half Year Ended March 31, 2021 | |
| Compliances- Compliance Certificate For The Half Year Ended March 31, 2021 | |
| Compliances-Reg.24(A)-Annual Secretarial Compliance | |
| Date of payment of Dividend | |
| Demise of Director | |
| Disclosure On Related Party Transactions For Half Year Ended March 31, 2021 | |
| Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations, 2011 | |
| Initial Disclosure to be made by an entity identified as a Large Corporate_FY22 | |
| Intimation Of Sad Demise Of Mrs.Gannabathula Subbayamma, Member Of Promoter Group Of The Company | |
| Intimation Of Submission Of Application To Stock Exchanges | |
| Loss of SC_11032022 | |
| Loss of SC_20122021 | |
| Loss of SC_29112021 | |
| Reg 30_Update on Nanakramguda Project | |
| Reporting Under SEBI (Prohibition Of Insider Trading) Regulations, 2015 | |
| Shifting Of Registered Office Of The Company With Effect From June 11, 2021 |
| Title | Download |
|---|---|
| Board approves Dividend | |
| Certificate Under Regulation 40(9) Of SEBI(LODR) Regulations, 2015 | |
| Changes In Key Managerial Personnel | |
| Clarification On Price Movement | |
| Clarification On Share Price Movement | |
| Compliance Certificate For The Period Ended March 31, 2020 | |
| Compliances- Certificate Under Regulation 40(9) Of SEBI(LODR) Regulations, 2015 | |
| Compliances- Compliance Certificate For The Half Year Ended September 30, 2020 | |
| Compliances-Reg.24(A)-Annual Secretarial Compliance | |
| Disclosure On Related Party Transactions For Half Year Ended March 31, 2020 | |
| Disclosure On Related Party Transactions For Half Year Ended September 30, 2020 | |
| Intimation For Change Of Contact Details Of The Company | |
| Loss of SC_04122020 | |
| Price movement clarification | |
| Reg 30_FDA Inspection | |
| Reg 30_Updates Unit III |
| Title | Download |
|---|---|
| Appointment of Statutory Auditors | |
| Board approves Dividend | |
| Certificate Under Regulation 40(9) Of LODR Regulation, 2015 | |
| Company Update - US FDA Inspection Unit l | |
| Compliances - Certificate Under Regulation 40(9) of SEBI (LODR) Regulations, 2015 | |
| Compliances - Compliance Certificate For The Period Ended September 30, 2019 | |
| Disclosure On Related Party Transactions For Half Year Ended September 30, 2019 | |
| Initial Disclosure to be made by an entity identified as a Large Corporate FY2020 | |
| Reg 30 US FDA Inspection Unit I | |
| Reg 30 US FDA Inspection | |
| Reg 24(A) - Annual Secretarial Compliance | |
| Resignation of Chief Financial Officer (CFO) | |
| Submission Of Half Yearly Disclosure On Related Party Transactions Pursuant To Regulation 23(9) | |
| Update In Respect Of Fund Raising By Issuance Of Debt Securities By Large Entities |
| Title | Download |
|---|---|
| Change in Management Appointment of Director | |
| Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011 | |
| Loss of SC - 13062018 | |
| Loss of SC-17012019 | |
| Loss of SC - 25072018 | |
| Loss of SC 26102018 | |
| Qualified Institutional Placement | |
| Scheme of Amalgamation and Arrangement Allotment | |
| Share Price Movement | |
| Transfer of Operations of Share Transfer Agent from Karvy Computershare Private Limited to Karvy Fintech Private limited | |
| Update on the Scheme of Amalgamation and Arrangement | |
| Update to Shareholders | |
| Update US FDA Inspection Unit II |
| Title | Download |
|---|---|
| CFO Appointment | |
| CFO Appointment D. Saharsh Rao | |
| Clarification | |
| Loss of SC - 25092017 | |
| Newspaper Adv - Loss of SC | |
| Notice in respect of proposed transfer of ordinary shares to the Investor Education and Protection Fund | |
| Purchase of Manufacturing facility | |
| Update on Nanakramguda Project | |
| Updates on Amalgamation, Merger, Demerge | |
| Updates US FDA Inspection Unit l |
